GLYCOPHOS
NDC 65219-346, Sodium Glycerophosphate, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-346
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA220381
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM GLYCEROPHOSPHATE ANHYDROUS216 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-346-20 | 65219034620 | 25 VIAL, SINGLE-DOSE in 1 CARTON (65219-346-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-346-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e887e473-f1a7-40f1-bd6e-c99e7db7420d
Use it
Look up 65219-346 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-346. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.